Navigation Links
Reportlinker Adds Global: Pharmaceuticals Industry Guide
Date:4/7/2011

NEW YORK, April 7, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global: Pharmaceuticals Industry Guide

http://www.reportlinker.com/p0470341/Global-Pharmaceuticals-Industry-Guide.html

Datamonitor's Global: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the Global Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes five-year forecasts for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences

Highlights

The global biotechnology market had total revenue of $200 billion in 2009, representing a compound annual growth rate (CAGR) of 10.2% for the period spanning 2005-2009.

The global generics market had total revenue of $149.7 billion in 2009, representing a compound annual growth rate (CAGR) of 11% for the period spanning 2005-2009.

The global life sciences tools and services market generated total revenues of $18.1 billion in 2009, representing a compound annual growth rate (CAGR) of 10.5% for the period spanning 2005-2009.

The global OTC pharmaceuticals market generated total revenues of $110.7 billion in 2009, representing a compound annual growth rate (CAGR) of 3.9% for the period spanning 2005-2009.

The global pharmaceuticals market is expected to have total revenue of $693 billion in 2010, representing a compound annual growth rate (CAGR) of 4.8% for the period spanning 2006-2010.

The global pharmaceuticals, biotechnology, and life sciences industry group generated total revenues of $1,071.7 billion in 2009, representing a compound annual growth rate (CAGR) of 6.7% for the period spanning 2005-2009.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

TABLE OF CONTENTS

GLOBAL BIOTECHNOLOGY 9

Market Overview 9

Market Value 11

Market Segmentation I 12

Market Segmentation II 13

Five Forces Analysis 14

Market Forecasts 21

GLOBAL GENERICS 23

Market Overview 23

Market Value 25

Market Volume 26

Market Segmentation II 27

Five Forces Analysis 28

Market Forecasts 36

GLOBAL LIFE SCIENCES TOOLS & SERVICES 39

Market Overview 39

Market Value 41

Market Segmentation I 42

Market Segmentation II 43

Market Share 44

Five Forces Analysis 45

Market Forecasts 53

GLOBAL OTC PHARMACEUTICALS 55

Market Overview 55

Market Value 57

Market Segmentation I 58

Market Segmentation II 59

Market Share 60

Five Forces Analysis 61

Market Distribution 69

Market Forecasts 70

GLOBAL PHARMACEUTICALS 72

Market Overview 72

Market Value 74

Market Segmentation I 75

Market Segmentation II 76

Market Share 77

Five Forces Analysis 78

Market Forecasts 88

GLOBAL PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES 90

Market Overview 90

Market Value 92

Market Segmentation I 94

Market Segmentation II 95

Market Share 96

Five Forces Analysis 98

Market Forecasts 108

APPENDIX 110

Data Research Methodology 110

About Datamonitor 111

Disclaimer 111

LIST OF TABLES

Table 1: Global biotechnology market value: $ billion, 2005–09 11

Table 2: Global biotechnology market segmentation I:% share, by value, 2009 12

Table 3: Global biotechnology Market Segmentation II: % share, by value, 2009 13

Table 4: Global biotechnology market value forecast: $ billion, 2009–14 21

Table 5: Global generics market value: $ billion, 2005–09 25

Table 6: Global generics market volume: volume penetration, 2005–09 26

Table 7: Global generics Market Segmentation II: % share, by value, 2009 27

Table 8: Global generics market value forecast: $ billion, 2009–14 36

Table 9: Global generics market volume forecast: volume penetration, 2009–14 37

Table 10: Global life sciences tools & services market value: $ billion, 2005–09 41

Table 11: Global life sciences tools & services market segmentation I:% share, by value, 2009 42

Table 12: Global life sciences tools & services Market Segmentation II: % share, by value, 2009 43

Table 13: Global life sciences tools & services market share: % share, by value, 2009 44

Table 14: Global life sciences tools & services market value forecast: $ billion, 2009–14 53

Table 15: Global OTC pharmaceuticals market value: $ million, 2005–09 57

Table 16: Global OTC pharmaceuticals market segmentation I:% share, by value, 2009 58

Table 17: Global OTC pharmaceuticals Market Segmentation II: % share, by value, 2009 59

Table 18: Global OTC pharmaceuticals market share: % share, by value, 2009 60

Table 19: Global OTC pharmaceuticals market distribution: % share, by value, 2009 69

Table 20: Global OTC pharmaceuticals market value forecast: $ million, 2009–14 70

Table 21: Global pharmaceuticals market value: $ billion, 2006–10(e) 74

Table 22: Global pharmaceuticals market segmentation I:% share, by value, 2010(e) 75

Table 23: Global pharmaceuticals Market Segmentation II: % share, by value, 2010(e) 76

Table 24: Global pharmaceuticals market share: % share, by value, 2010(e) 77

Table 25: Global pharmaceuticals market value forecast: $ billion, 2010–15 88

Table 26: Global pharmaceuticals, biotechnology & life sciences industry value: $ billion, 2005–09 92

Table 27: Global pharmaceuticals, biotechnology & life sciences industry segmentation I:% share, by value, 2009 94

Table 28: Global pharmaceuticals, biotechnology & life sciences industry segmentation II: % share, by value, 2009 95

Table 29: Global pharmaceuticals, biotechnology & life sciences industry share: % share, by value, 2009 96

Table 30: Global pharmaceuticals, biotechnology & life sciences industry value forecast: $ billion, 2009–14 108

LIST OF FIGURES

Figure 1: Global biotechnology market value: $ billion, 2005–09 11

Figure 2: Global biotechnology market segmentation I:% share, by value, 2009 12

Figure 3: Global biotechnology Market Segmentation II: % share, by value, 2009 13

Figure 4: Forces driving competition in the global biotechnology market, 2009 14

Figure 5: Drivers of buyer power in the global biotechnology market, 2009 15

Figure 6: Drivers of supplier power in the global biotechnology market, 2009 16

Figure 7: Factors influencing the likelihood of new entrants in the global biotechnology market, 2009 17

Figure 8: Factors influencing the threat of substitutes in the global biotechnology market, 2009 19

Figure 9: Drivers of degree of rivalry in the global biotechnology market, 2009 20

Figure 10: Global biotechnology market value forecast: $ billion, 2009–14 22

Figure 11: Global generics market value: $ billion, 2005–09 25

Figure 12: Global generics market volume: volume penetration, 2005–09 26

Figure 13: Global generics Market Segmentation II: % share, by value, 2009 27

Figure 14: Forces driving competition in the global generics market, 2009 28

Figure 15: Drivers of buyer power in the global generics market, 2009 30

Figure 16: Drivers of supplier power in the global generics market, 2009 31

Figure 17: Factors influencing the likelihood of new entrants in the global generics market, 2009 32

Figure 18: Factors influencing the threat of substitutes in the global generics market, 2009 34

Figure 19: Drivers of degree of rivalry in the global generics market, 2009 35

Figure 20: Global generics market value forecast: $ billion, 2009–14 36

Figure 21: Global generics market volume forecast: volume penetration, 2009–14 38

Figure 22: Global life sciences tools & services market value: $ billion, 2005–09 41

Figure 23: Global life sciences tools & services market segmentation I:% share, by value, 2009 42

Figure 24: Global life sciences tools & services Market Segmentation II: % share, by value, 2009 43

Figure 25: Global life sciences tools & services market share: % share, by value, 2009 44

Figure 26: Forces driving competition in the global life sciences tools & services market, 2009 45

Figure 27: Drivers of buyer power in the global life sciences tools & services market, 2009 47

Figure 28: Drivers of supplier power in the global life sciences tools & services market, 2009 48

Figure 29: Factors influencing the likelihood of new entrants in the global life sciences tools & services market, 2009 49

Figure 30: Factors influencing the threat of substitutes in the global life sciences tools & services market, 2009 51

Figure 31: Drivers of degree of rivalry in the global life sciences tools & services market, 2009 52

Figure 32: Global life sciences tools & services market value forecast: $ billion, 2009–14 54

Figure 33: Global OTC pharmaceuticals market value: $ million, 2005–09 57

Figure 34: Global OTC pharmaceuticals market segmentation I:% share, by value, 2009 58

Figure 35: Global OTC pharmaceuticals Market Segmentation II: % share, by value, 2009 59

Figure 36: Global OTC pharmaceuticals market share: % share, by value, 2009 60

Figure 37: Forces driving competition in the global OTC pharmaceuticals market, 2009 61

Figure 38: Drivers of buyer power in the global OTC pharmaceuticals market, 2009 63

Figure 39: Drivers of supplier power in the global OTC pharmaceuticals market, 2009 64

Figure 40: Factors influencing the likelihood of new entrants in the global OTC pharmaceuticals market, 2009 65

Figure 41: Factors influencing the threat of substitutes in the global OTC pharmaceuticals market, 2009 67

Figure 42: Drivers of degree of rivalry in the global OTC pharmaceuticals market, 2009 68

Figure 43: Global OTC pharmaceuticals market distribution: % share, by value, 2009 69

Figure 44: Global OTC pharmaceuticals market value forecast: $ million, 2009–14 71

Figure 45: Global pharmaceuticals market value: $ billion, 2006–10(e) 74

Figure 46: Global pharmaceuticals market segmentation I:% share, by value, 2010(e) 75

Figure 47: Global pharmaceuticals Market Segmentation II: % share, by value, 2010(e) 76

Figure 48: Global pharmaceuticals market share: % share, by value, 2010(e) 77

Figure 49: Forces driving competition in the global pharmaceuticals market, 2010 78

Figure 50: Drivers of buyer power in the global pharmaceuticals market, 2010 79

Figure 51: Drivers of supplier power in the global pharmaceuticals market, 2010 81

Figure 52: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2010 83

Figure 53: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2010 85

Figure 54: Drivers of degree of rivalry in the global pharmaceuticals market, 2010 87

Figure 55: Global pharmaceuticals market value forecast: $ billion, 2010–15 89

Figure 56: Global pharmaceuticals, biotechnology & life sciences industry value: $ billion, 2005–09 93

Figure 57: Global pharmaceuticals, biotechnology & life sciences industry segmentation I:% share, by value, 2009 94

Figure 58: Global pharmaceuticals, biotechnology & life sciences industry segmentation II: % share, by value, 2009 95

Figure 59: Global pharmaceuticals, biotechnology & life sciences industry share: % share, by value, 2009 97

Figure 60: Forces driving competition in the global pharmaceuticals, biotechnology & life sciences industry, 2009 98

Figure 61: Drivers of buyer power in the global pharmaceuticals, biotechnology & life sciences industry, 2009 100

Figure 62: Drivers of supplier power in the global pharmaceuticals, biotechnology & life sciences industry, 2009 102

Figure 63: Factors influencing the likelihood of new entrants in the global pharmaceuticals, biotechnology & life sciences industry, 2009 103

Figure 64: Factors influencing the threat of substitutes in the global pharmaceuticals, biotechnology & life sciences industry, 2009 105

Figure 65: Drivers of degree of rivalry in the global pharmaceuticals, biotechnology & life sciences industry, 2009 107

Figure 66: Global pharmaceuticals, biotechnology & life sciences industry value forecast: $ billion, 2009–14 109

To order this report:

: Global: Pharmaceuticals Industry Guide

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Asian Vaccine Markets
2. Reportlinker Adds Microscopy Market in Latin America
3. Reportlinker Adds Leading Anti-Cancer Drugs: World Market Prospects 2011-2021
4. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
5. Reportlinker Adds World Anti-Obesity Drug Market 2011-2021
6. Reportlinker Adds World Biological Drugs Market 2011-2021
7. Reportlinker Adds World Influenza Vaccines Market 2011-2021
8. Reportlinker Adds Drug Delivery in Cancer - technologies, markets and companies
9. Reportlinker Adds Enzymes in Drug Manufacturing
10. Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects
11. Reportlinker Adds Pain Therapeutics - Drugs, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... 2016 The global dental bone ... a CAGR of 10.6% within a forecast period from ... bn in 2013. Owing to favorable factors at play ... bn by the end of this forecast period, i.e. ... holistic representation in a research report published by Transparency ...
(Date:5/31/2016)... NESS ZIONA, Israel , ... a regenerative medicine company utilizing its proprietary plant-based rhCollagen ... has received authorization from the Chief Scientist of ... approximately 50% of its NIS 12 million development project ... million, measurably higher than last year,s authorized grant, which ...
(Date:5/30/2016)... , May 30, 2016 ... research report "Healthcare Biometrics Market by Technology ... Voice)), Multifactor, Multimodal), Application (Workforce Management), End ... to 2021", published by MarketsandMarkets, the market ... by 2021 from USD 1,182.6 Million by ...
Breaking Medicine Technology:
(Date:5/31/2016)... , ... May 31, 2016 , ... Throughout the day, adults often find themselves reaching ... and awareness, but what they could be reaching for instead is a cup of Matcha ... are grown in Japan. This sacred tea is harvested from early June to mid-July, when ...
(Date:5/31/2016)... ... May 31, 2016 , ... Presence ... it has been included by Gartner, Inc. in the Contact Center Infrastructure Magic ... Contact Center Infrastructure technologies, some of which include: Computer-telephony integration (CTI)/Web services ...
(Date:5/31/2016)... TEXAS (PRWEB) , ... May 31, 2016 , ... ... live in Greater Houston Healthconnect’s (Healthconnect) regional health information exchange, which enables physicians ... medical records for their patients from other participating organizations in the exchange. SJMC’s ...
(Date:5/31/2016)... GA (PRWEB) , ... May 31, 2016 , ... ... readmissions using a mix of advanced Artificial Intelligence (AI) and the latest in ... solution. The medical center is integrating predictive analytic outputs directly into the clinical ...
(Date:5/31/2016)... ... 31, 2016 , ... DDL, Inc. announced today it has expanded the scope ... include ISO 594-1 and ISO 594-2 testing for conical (Luer) fittings. , A ... two medical devices (e.g. a syringe and hypodermic needle) that carry small volumes of ...
Breaking Medicine News(10 mins):